Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in Interest ReceivablesChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iBio (IBIO) Change in Receivables (2016 - 2025)

Historic Change in Receivables for iBio (IBIO) over the last 15 years, with Q3 2025 value amounting to $65000.0.

  • iBio's Change in Receivables changed N/A to $65000.0 in Q3 2025 from the same period last year, while for Dec 2025 it was $65000.0, marking a year-over-year increase of 10670.79%. This contributed to the annual value of -$1.0 million for FY2023, which is 21286.68% down from last year.
  • Latest data reveals that iBio reported Change in Receivables of $65000.0 as of Q3 2025.
  • In the past 5 years, iBio's Change in Receivables ranged from a high of $893000.0 in Q1 2022 and a low of -$900000.0 during Q1 2023
  • Its 4-year average for Change in Receivables is $24818.2, with a median of $54000.0 in 2022.
  • Per our database at Business Quant, iBio's Change in Receivables surged by 32932.69% in 2022 and then crashed by 162500.0% in 2023.
  • Over the past 4 years, iBio's Change in Receivables (Quarter) stood at -$96000.0 in 2021, then rose by 11.46% to -$85000.0 in 2022, then grew by 18.82% to -$69000.0 in 2023, then surged by 194.2% to $65000.0 in 2025.
  • Its Change in Receivables was $65000.0 in Q3 2025, compared to -$69000.0 in Q2 2023 and -$900000.0 in Q1 2023.